Form 4: Frazier Life Sciences X, L.P. Reports Transaction in HilleVax, Inc. (HLVX)
SEC Form 4 Filing
Frazier Life Sciences X, L.P. reports the acquisition and disposition of HilleVax, Inc. common stock on April 4, 2024.
Summary
- On April 4, 2024, Frazier Life Sciences X, L.P. acquired 8,850 shares of HilleVax, Inc. common stock at a price of $14.5 per share.
- On the same day, Frazier Life Sciences X, L.P. disposed of 8,544,187 shares.
- Following these transactions, Frazier Life Sciences X, L.P. beneficially owns 8,544,187 shares of HilleVax, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, and doesn't inherently convey positive or negative sentiment. It's a factual disclosure.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for significant shareholders, like Frazier Life Sciences X, L.P., and provides transparency into their transactions in HilleVax, Inc. stock.
Stakeholder Impact
- Shareholders may react to the reported transactions, potentially influencing the stock price.
Key Dates
| Date | Description |
|---|---|
| 04/04/2024 | Date of the reported stock acquisition and disposition. |
| 04/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.